Naturally-occurring CD4+CD25+ immunoregulatory T cells: Central players in the arena of peripheral tolerance

Seminars in Immunology

Volumn 16, Issue 2, 2004, Pages 81-88

  Piccirillo, Ciriaco A ^a   Shevach, Ethan M ^b  

^a MCGILL UNIVERSITY   (Canada)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Autoimmune disease; CD4+CD25+; Immunoregulation; Inflammation; Regulatory T cells; Suppression; Tolerance

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CYTOKINE; INTERLEUKIN 2 RECEPTOR;

ANTIGEN SPECIFICITY; FOREIGN BODY; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PHENOTYPE; QUESTIONNAIRE; REVIEW; T LYMPHOCYTE;

EID: 1242295282     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2003.12.003     Document Type: Article

References (54)

1. Bach J.F., Chatenoud L. Tolerance to islet autoantigens in type 1 diabetes. Annu. Rev. Immunol. 19:2001;131-161.
2. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell. 101:2000;455-458.
3. Shevach E. Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18:2000;423-449.
4. Maloy K.J., Powrie F. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:2001;816-822.
5. Bach J.F. Organ-specific autoimmunity. Immunol. Today. 16:1995;353-355.
6. + suppressor T cells: more questions than answers. 2002;2:389-400.
7. Bach J.F. Regulatory T cells under scrutiny. Nat. Rev. Immunol. 3:2003;189-198.
8. Gershon R.K., Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology. 18:1970;723-735.
9. Gershon R.K., Kondo K. Infectious immunological tolerance. Immunology. 21:1971;903-914.
10. King C., Sarvetnick N. Organ-specific autoimmunity. Curr. Opin. Immunol. 9:1997;863-871.
11. Chen Y., Kuchroo V.K., Inobe J.-I., Hafler D.A., Weiner H.L. Regulatory T-cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
12. Groux H., Powrie F. Regulatory T cells and inflammatory bowel disease. Immunol. Today. 20:1999;442-446.
13. Groux H.et al. Generation of a novel regulatory CD4+ T cell population which inhibits antigen-specific T cell responses. Nature. 389:1997;737-742.
14. Sharif S., Arreaza G.A., Zucker P., Mi Q.S., Delovitch T.L. Regulation of autoimmune disease by natural killer T cells. J. Mol. Med. 8:2002;290-300.
15. Asano M., Toda M., Sakaguchi N., Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T-cell subpopulation. J. Exp. Med. 184:1996;387-396.
16. Read S., Mauze S., Asseman C., Bean A., Coffman R., Powrie F. CD38+ CD45RB(low) CD4+ T cells: a population of T cells with immune regulatory activities in vitro. Eur. J. Immunol. 28(11):1998;3435-3447.
17. Singh B., Read S., Asseman C., Malmstrom V., Mottet C., Stephens L.A.et al. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182:2001;190-200.
18. Herbelin A., Gombert J.M., Lepault F., Bach J.F., Chatenoud L. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse. J. Immunol. 5:1998;2620-2628.
19. + T cells in autoimmune diabetes. Nat. Immunol. 12:2001;1117-1125.
20. +) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid- induced TNF receptor. Immunity. 16:2002;311-323.
21. Shevach E.M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:2002;389-400.
22. + regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc. Natl. Acad. Sci. U S A. 99:2002;8213-8218.
23. Seddon B., Mason D. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J. Exp. Med. 189:1999;877-881.
24. Taguchi O., Nishizuka Y. Self tolerance and localized autoimmunity. Mouse models of autoimmune disease that suggest tissue-specific suppressor T cells are involved in self-tolerance. J. Exp. Med. 165:1987;146-156.
25. Taguchi O.et al. Tissue-specific suppressor T cells involved in self-tolerance are activated extrathymically by selfantigens. Immunology. 82:1994;365-369.
26. Garza K.M., Agersborg S.S., Baker E., Tung K.S.T. Persistence of physiological antigen is required for the regulation of self-tolerance. J. Immunol. 164:2000;3982-3989.
27. Jordan M.S., Boesteanu A., Reed A.J., Petrone A.L., Holenbeck A.E., Lerman M.A.et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2:2001;301-306.
28. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182:2001;18-32.
29. Tang Q., Henriksen K.J., Boden E.K., Tooley A.J., Ye J., Subudhi S.K.et al. CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J. Immunol. 171:2003;3348-3352.
30. Salomon B., Bluestone J.A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Ann. Rev. Immunol. 19:2001;225-252.
31. + immunoregulatory T cells that control autoimmune diabetes. Immunity. 12:2000;431-440.
32. Schimpl A., Berberich I., Kneitz B., Kramer S., Santner-Nanan B., Wagner S.et al. IL-2 and autoimmune disease. Cytokine Growth Factor Rev. 13:2002;369-378.
33. Malek T.R., Yu A., Vincek V., Scibelli P., Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Ralpha-deficient mice: implications for the nonredundant function of IL-2. Immunity. 17:2002;167-178.
34. Cambineri E., Torgerson T.R., Ochs H.D. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. 15:2003;430-435.
35. + T regulatory cells. Nat. Immunol. 4:2003;337-342.
36. + regulatory T cells. Nat. Immunol. 4:2003;330-336.
37. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:2003;1057-1061.
38. + suppressor T cells. Immunol. Rev. 182:2001;58-67.
39. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:1998;287-296.
40. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10:1998;1969-1980.
41. + immunoregulatory cells. J. Immunol. 167:2001;1137-1140.
42. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M., Demengeot J.et al. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197:2003;403-411.
43. Zheng S.G., Gray J.D., Ohtsuka K., Yamagiwa S., Horwitz D.A. Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors. J. Immunol. 169:2002;4183-4189.
44. Barrat F.J., Cua D.J., Boonstra A., Richards D.F., Crain C., Savelkoul H.F.et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195:2002;603-616.
45. van Maurik A., Herber M., Wood K.J., Jones N.D. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J. Immunol. 169:2002;5401-5404.
46. Wakkach A., Fournier N., Brun V., Breittmayer J.P., Cottrez F., Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity. 18:2003;605-617.
47. Belghith M., Bluestone J.A., Barriot S., Megret J., Bach J.F., Chatenoud L. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. 9:2003;1202-1208.
48. +) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J. Exp. Med. 196:2002;237-246.
49. +) T cells. J. Autoimmun. 16:2001;115-123.
50. + regulatory T cells control Leishmania major persistence and immunity. Nature. 420:2002;502-507.
51. Prud'homme G.J., Piccirillo C.A. The inhibitory effects of transforming growth factor beta-1 (TGF-β1) in autoimmune diseases. J. Autoimmunity. 14:2000;23-42.
52. Jonuleit H., Schmitt E., Kakirman H., Stassen M., Knop J., Enk A.H. Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J. Exp. Med. 196(2):2002;255-260.
53. Kukreja A., Cost G., Marker J., Zhang C., Sun Z., Lin-Su K.et al. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109:2002;131-140.
54. Barthlott T., Kassiotis G., Stockinger B. T cell regulation as a side effect of homeostasis and competition. J. Exp. Med. 197(4):2003;451-460.